Facial muscle spasms: an Australian study

Area of Science:

• Neurology
• Ophthalmology
• Dermatology

Background:

• Facial muscle dystonias, including blepharospasm, hemifacial spasm, and Meige's syndrome, are rare conditions.
• Patient experiences highlight a significant lack of awareness and understanding within the medical community regarding these disorders.

Purpose of the Study:

• To investigate diagnostic delays, practitioner attitudes, lifestyle impacts, and treatment outcomes for patients with facial muscle dystonias.
• To assess the effectiveness of botulinum toxin injections in managing symptoms of these conditions.

Main Methods:

• A survey was conducted using questionnaires distributed to patients diagnosed with blepharospasm, hemifacial spasm, or Meige's syndrome.
• Patients presenting to three ophthalmologists specializing in botulinum toxin treatments over a 12-month period were included.

Main Results:

• Patients consulted an average of 4.4 practitioners before receiving a correct diagnosis, often waiting years for satisfactory treatment.
• Two-thirds of consulted practitioners were unaware of the conditions; 55% of patients reported psychological issues linked to onset.
• Botulinum toxin injections were found to be effective in providing symptom relief for the majority of patients.

Conclusions:

• Facial muscle dystonias are under-recognized, leading to prolonged diagnostic delays and patient distress.
• Stress may contribute to the symptomatic onset of these conditions, and pain is a common presenting symptom.
• Botulinum toxin is an effective treatment option for managing facial spasms associated with these dystonias.